Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II

J Immunol. 1996 Jul 1;157(1):255-64.

Abstract

Successful resolution of salmonellosis in naive mice depends in large part upon IL-12-induced IFN-gamma production to eliminate this intracellular pathogen of macrophages. In the present study we questioned the contribution that expression of substance P receptors makes to the protective response following oral inoculation with a lethal dose of Salmonella. Such a relationship was suggested when oral inoculation with Salmonella induced rapid and dramatic increases in substance P receptor mRNA expression within Peyer's patches and mesenteric lymph nodes and subsequently in the spleen. The importance of substance P receptor expression in vivo was further suggested by pretreatment of mice with the substance P antagonist, spantide II, before oral inoculation with Salmonella. Mice pretreated with spantide II and then orally inoculated developed advanced salmonellosis and had significantly reduced survival rates compared with mice pretreated with a control peptide. Treatment with spantide II significantly reduced early Salmonella-induced IL-12p4O and IFN-gamma mRNA expression at mucosal sites, suggesting a mechanism for the reduced ability of spantide II-treated mice to resist this pathogen. Increased susceptibility to salmonellosis was not due to 1) spantide II-induced alterations in the uptake of this pathogen from the gut, 2) global spantide II-mediated immune suppression, or 3) nonsubstance P receptor-mediated effects of spantide II on macrophages. The ability of Salmonella to induce substance P receptor expression on cultured macrophages suggested that one mechanism for resistance against this intracellular pathogen might be a direct effect of substance P on this cell population.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cells, Cultured
  • Disease Susceptibility
  • Female
  • Interferon-gamma / biosynthesis
  • Interleukin-12 / biosynthesis
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / immunology
  • Lymphocyte Activation / drug effects
  • Macrophage Activation / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • RNA, Messenger / biosynthesis
  • Receptors, Neurokinin-1 / biosynthesis
  • Receptors, Neurokinin-1 / genetics
  • Salmonella Infections, Animal / etiology*
  • Salmonella Infections, Animal / immunology*
  • Salmonella Infections, Animal / mortality
  • Substance P / administration & dosage
  • Substance P / analogs & derivatives*
  • Substance P / antagonists & inhibitors*
  • Substance P / biosynthesis
  • Substance P / genetics
  • Substance P / pharmacology

Substances

  • RNA, Messenger
  • Receptors, Neurokinin-1
  • spantide II
  • Interleukin-12
  • Substance P
  • Interferon-gamma